In Development
Key Benefits
Unmet Need
70,000 mothers & 500,000 babies are undiagnosed and untreated for Preeclampsia
Global Impact
Scalable & portable testing technology
Innovation
Sensitive to the femptogram or one quadrillionth of a gram
XALIVA® PE
Contact UsHigh Accuracy
On-screen PlGF results with
high sensitivity
high sensitivity
Onsite Testing
Point of care testing enables providers
and patients great flexibility
and patients great flexibility
Cost Effective
Significantly lower cost than current
methods
methods
Successful Clinical Study
A clinical study validated the accurate detection
in both positive and negative preeclampsia samples
Published Clinical Study
Chaudhary RK et al., Polymeric optical fiber biosensor with PAMAM dendrimer-based surface modification and PlGF detection for pre-eclampsia diagnosis. Biosensors and Bioelectronics, 257:2024.
